267 related articles for article (PubMed ID: 18801761)
21. [Antiphospholipid antibody syndrome].
Chakoutio V; Ries F
Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174
[TBL] [Abstract][Full Text] [Related]
22. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
[TBL] [Abstract][Full Text] [Related]
23. Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome.
Veres K; Szodoray P; Szekanecz Z; Lakos G; Kiss E; Laczik R; Sipka S; Bodolay E; Zeher M; Muszbek L; Szegedi G; Soltész P
Lupus; 2010 Nov; 19(13):1520-6. PubMed ID: 20685773
[TBL] [Abstract][Full Text] [Related]
24. European registry of babies born to mothers with antiphospholipid syndrome: a result update.
Boffa MC; Lachassinne E; Boinot C; De Carolis S; Rovere-Querini P; Avcin T; Biasini-Rebaioli C; Le Toumelin P; Aurousseau MH; Tincani A
Lupus; 2009 Sep; 18(10):900-4. PubMed ID: 19671790
[TBL] [Abstract][Full Text] [Related]
25. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
Reshetniak TM; Seredavkina nV; Mach ES; Aleksandrova EN; Novikov AA; Cherkasova MV; Nasonov EL
Ter Arkh; 2008; 80(10):60-7. PubMed ID: 19105418
[TBL] [Abstract][Full Text] [Related]
26. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort.
Boffa MC; Boinot C; De Carolis S; Rovere-Querini P; Aurousseau MH; Allegri F; Nicaise-Roland P; Barra A; Botta A; Ambrozic A; Avcin T; Tincani A
Thromb Haemost; 2009 Jul; 102(1):25-8. PubMed ID: 19572063
[TBL] [Abstract][Full Text] [Related]
27. Lessons from the "Euro-Phospholipid" project.
Cervera R
Autoimmun Rev; 2008 Jan; 7(3):174-8. PubMed ID: 18190874
[TBL] [Abstract][Full Text] [Related]
28. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS.
Cervera R; Espinosa G; Cordero A; Oltra MR; Unzurrunzaga A; Rossiñol T; Plaza J; Bucciarelli S; Ramos-Casals M; Ingelmo M; Asherson RA; Font J;
Semin Arthritis Rheum; 2007 Apr; 36(5):287-96. PubMed ID: 17207521
[TBL] [Abstract][Full Text] [Related]
29. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry".
Cervera R; Bucciarelli S; Plasín MA; Gómez-Puerta JA; Plaza J; Pons-Estel G; Shoenfeld Y; Ingelmo M; Espinos G;
J Autoimmun; 2009; 32(3-4):240-5. PubMed ID: 19324520
[TBL] [Abstract][Full Text] [Related]
30. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
31. [Antiphospholipid syndrome and pregnancy: Obstetrical prognosis according to the type of APS].
Delesalle C; de Vienne C; Le Hello C; Verspyck E; Dreyfus M
J Gynecol Obstet Biol Reprod (Paris); 2015 May; 44(5):463-70. PubMed ID: 25042624
[TBL] [Abstract][Full Text] [Related]
32. Obstetrical antiphospholipid syndrome.
Wu S; Stephenson MD
Semin Reprod Med; 2006 Feb; 24(1):40-53. PubMed ID: 16418977
[TBL] [Abstract][Full Text] [Related]
33. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.
Muscal E; Brey RL
Int J Clin Pract; 2007 Sep; 61(9):1561-8. PubMed ID: 17596187
[TBL] [Abstract][Full Text] [Related]
34. Stroke and antiphospholipid syndrome: the treatment debate.
Ruiz-Irastorza G; Khamashta MA
Rheumatology (Oxford); 2005 Aug; 44(8):971-4. PubMed ID: 15840602
[TBL] [Abstract][Full Text] [Related]
35. European registry of infants born to mothers with antiphospholipid syndrome: preliminary results.
Motta M; Lachassinne E; Boffa MC; Tincani A; Avcin T; De Carolis S; Aurousseau MH; Le Toumelin P; Lojacono A; De Carolis MP; Chirico G
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):25-7. PubMed ID: 21089714
[TBL] [Abstract][Full Text] [Related]
36. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
37. Recurrent miscarriage and long-term thrombosis risk: a case-control study.
Quenby S; Farquharson RG; Dawood F; Hughes AM; Topping J
Hum Reprod; 2005 Jun; 20(6):1729-32. PubMed ID: 15774543
[TBL] [Abstract][Full Text] [Related]
38. Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
Bazzan M; Vaccarino A; Stella S; Sciascia S; Montaruli B; Bertero MT; Carignola R; Roccatello D;
Lupus; 2016 Apr; 25(5):479-85. PubMed ID: 26657216
[TBL] [Abstract][Full Text] [Related]
39. The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): a preliminary first year report.
Alijotas-Reig J; Ferrer-Oliveras R;
Lupus; 2012 Jun; 21(7):766-8. PubMed ID: 22635227
[TBL] [Abstract][Full Text] [Related]
40. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients.
Bucciarelli S; Espinosa G; Cervera R; Erkan D; Gómez-Puerta JA; Ramos-Casals M; Font J; Asherson RA;
Arthritis Rheum; 2006 Aug; 54(8):2568-76. PubMed ID: 16868979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
